MCC950NLRP3Interleukin-23/Interleukin-17

Yi Li1, Xiaocong Li1, Tao Gu2

  • 1Department of Neurology, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.

PubMed
概括

在NLRP3炎症酶驱动吉兰-巴雷综合征 (GBS) 通过上调IL-23/IL-17轴. 使用MCC950抑制这种途径显示了GBS治疗的治疗潜力.